[
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "G",
        "alt": "G2019S",
        "position": "2019"
      },
      "variant_string_id": "LRRK2 G2019S"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset PD (Parkinson’s disease).",
        "judgment": "Yes",
        "reasoning": "The paper clearly defines that mutations in the LRRK2 gene lead to Parkinson's Disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study uses an enzyme activity assay.",
        "judgment": "Yes",
        "reasoning": "The paper describes using an enzyme activity assay, which effectively models the disease pathogenesis as it measures the protein's function."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls and replicates were used.",
        "judgment": "Yes",
        "reasoning": "The paper includes both wild-type and mutant controls and the experiments were performed in triplicate."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "OddsPath for the G2019S variant was not provided but it significantly increased enzyme activity.",
        "judgment": "",
        "reasoning": "The paper does not provide a direct OddsPath value, but it does state that the G2019S variant significantly increases enzyme activity, suggesting pathogenicity."
      }
    ],
    "overall_conclusion": "The functional evidence supports a pathogenic effect for the G2019S variant in LRRK2 based on its significant increase in enzyme activity."
  },
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "A",
        "alt": "",
        "position": ""
      },
      "variant_string_id": "LRRK2 Wild-type"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset PD (Parkinson’s disease).",
        "judgment": "Yes",
        "reasoning": "The paper clearly defines that mutations in the LRRK2 gene lead to Parkinson's Disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study uses an enzyme activity assay.",
        "judgment": "Yes",
        "reasoning": "The paper describes using an enzyme activity assay, which effectively models the disease pathogenesis as it measures the protein's function."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls and replicates were used.",
        "judgment": "Yes",
        "reasoning": "The paper includes both wild-type and mutant controls and the experiments were performed in triplicate."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "OddsPath for the wild-type LRRK2 was not provided but it showed no significant increase in enzyme activity.",
        "judgment": "",
        "reasoning": "The paper does not provide a direct OddsPath value, but it does state that the wild-type LRRK2 showed no significant increase in enzyme activity."
      }
    ],
    "overall_conclusion": "The functional evidence suggests no pathogenic effect for the wild-type LRRK2 based on its lack of significant increase in enzyme activity."
  },
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "A",
        "alt": "R1441C",
        "position": "1441"
      },
      "variant_string_id": "LRRK2 R1441C"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset PD (Parkinson’s disease).",
        "judgment": "Yes",
        "reasoning": "The paper clearly defines that mutations in the LRRK2 gene lead to Parkinson's Disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study uses an enzyme activity assay.",
        "judgment": "Yes",
        "reasoning": "The paper describes using an enzyme activity assay, which effectively models the disease pathogenesis as it measures the protein's function."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls and replicates were used.",
        "judgment": "Yes",
        "reasoning": "The paper includes both wild-type and mutant controls and the experiments were performed in triplicate."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "OddsPath for the R1441C variant was not provided but it showed no significant increase in enzyme activity.",
        "judgment": "",
        "reasoning": "The paper does not provide a direct OddsPath value, but it does state that the R1441C variant showed no significant increase in enzyme activity."
      }
    ],
    "overall_conclusion": "The functional evidence suggests no pathogenic effect for the R1441C variant in LRRK2 based on its lack of significant increase in enzyme activity."
  },
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "A",
        "alt": "G2385R",
        "position": "2385"
      },
      "variant_string_id": "LRRK2 G2385R"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset PD (Parkinson’s disease).",
        "judgment": "Yes",
        "reasoning": "The paper clearly defines that mutations in the LRRK2 gene lead to Parkinson's Disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study uses an enzyme activity assay.",
        "judgment": "Yes",
        "reasoning": "The paper describes using an enzyme activity assay, which effectively models the disease pathogenesis as it measures the protein's function."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls and replicates were used.",
        "judgment": "Yes",
        "reasoning": "The paper includes both wild-type and mutant controls and the experiments were performed in triplicate."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "OddsPath for the G2385R variant was not provided but it showed a significant decrease in enzyme activity.",
        "judgment": "",
        "reasoning": "The paper does not provide a direct OddsPath value, but it does state that the G2385R variant significantly decreases enzyme activity."
      }
    ],
    "overall_conclusion": "The functional evidence supports a pathogenic effect for the G2385R variant in LRRK2 based on its significant decrease in enzyme activity."
  }
]